As the leader of Greatbatch Medical, Mauricio Arellano is responsible for driving the design and manufacture of critical technologies for the orthopaedic, cardiac rhythm management, neuromodulation and vascular access markets. Prior to joining Greatbatch, he held various management positions at Tyco Healthcare (now Covidien) and Sony. Arellano currently serves on the Board of Directors of the Buffalo Museum of Science, and is Vice Chairman of MedTech's Board of Directors.
BONEZONE: Kindly begin with some background. Who is Greatbatch Medical?
Mauricio Arellano: Greatbatch Medical is a leading developer and manufacturer of critical technologies and medical devices for the orthopaedic and other markets, including cardiac rhythm management, neuromodulation and vascular access.
Wilson Greatbatch, co-inventor of the first successfully implanted pacemaker in the U.S., founded our company in 1970. He recognized the critical importance of the power source to the success of the pacemaker, and subsequently built a business to execute on his lifelong vision of partnering with our customers to provide clinicians with better treatment options to improve patient outcomes.
Today we employ more than 2,000 associates distributed across a global footprint of ten facilities located in Indiana, Minnesota, New York, France, Mexico and Switzerland. As a company, we continue to evolve every day, looking for new and better ways to create value for all our key stakeholders, while helping to save and improve the lives of millions of people around the world. This combination makes our efforts incredibly rewarding.
- Next >>